Biotech Products Services and Research, Inc. Announces Successful Trial Production of Company's First Amniotic Allograft Product

January 12, 2017 4:00 PM

MIAMI, FL / ACCESSWIRE / January 12, 2017 / Biotech Products Services & Research Inc. (OTC PINK: BPSR) ("Company") today announced that its wholly owned subsidiary, Anu Life Sciences Inc. ("Anu"), has successfully completed several trial production runs of its first amniotic allograft biological product ("New Amnio Product"). The New Amnio Product represents the first of several amniotic-based biologics products that the Company intends to...

Read more

Accurexa Files Patent Application for the Combination of a PARP inhibitor with its ACX-31 Local Chemotherapy Wafer

January 10, 2017 11:17 AM

WALNUT CREEK, CA / ACCESSWIRE / January 10, 2017 / Accurexa Inc. (the "Company") (OTCQB: ACXA), a development-stage biotechnology company focused on the targeted delivery of therapies, announced today that it filed a new patent application related to the combination therapy of a PARP inhibitor and Accurexa's ACX-31 local temozolomide slow-release wafer polymer formulation for the treatment of solid tumors. PARP (Poly ADP Ribose Polymerase) is a...

Read more

Cell MedX Corp. Receives Data from Observational Trials in Manilla, Philippines

January 10, 2017 7:49 AM

CARSON CITY, NV / ACCESSWIRE / January 10, 2017 / Cell MedX Corp. (OTCQB: CMXC), Cell MedX Corp. ("Cell MedX" or the "Company"), announces that it has received more positive observational results from our distributor, Mr. Greg Pek, in Manilla, Philippines. Mr. Greg Pek has been conducting observational trials with the supervision of Dr. Caballeros over the past five months and has recently added Mr. Cesar Diones, a Physiotherapist, to assist...

Read more

Cell MedX Corp. Receives First Commercial eBalance Pro Wellness Devices

January 9, 2017 8:06 AM

CARSON CITY, NV / ACCESSWIRE / January 9, 2017 / Cell MedX Corp. (OTCQB: CMXC), Cell MedX Corp. ("Cell MedX" or the "Company"), is pleased to announce that it has received its first eBalance Pro wellness devices ready for commercial distribution. These wellness devices are designed to promote general wellness and alleviate pain caused by chronic conditions such as: sciatica, neuropathy and arthritic pain. The eBalance Pro wellness device is an...

Read more

American Cryostem 2016 Year End Update

January 4, 2017 8:00 AM

EATONTOWN, NJ / ACCESSWIRE / January 4, 2017 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today released Summary corporate and financial highlight information regarding the Company's year ending September 30, 2016; The Company's Total Revenue increased 75% in...

Read more

Abattis Issues Common Shares

December 16, 2016 6:32 PM

VANCOUVER, BC / ACCESSWIRE / December 16, 2016 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CNSX: ATT) (the "Company" or "Abattis"), announces that today the Company issued 534,389 common shares as compensation for services to consultants, directors and employees of the Company for the month ended November 30, 2016 and in respect of prior months outstanding, no legend was required on any of the issued shares. Abattis is also pleased to...

Read more

Kasten, Inc. Announces Signed Term Sheet to Joint Venture with a Leading Medical Research Firm

December 15, 2016 8:00 AM

SILVER SPRINGS, NV / ACCESSWIRE / December 15, 2016 / Kasten, Inc. (KAST) announced today it has signed a term sheet to joint venture with Pettersson Adams Medical Research. Pettersson is engaged in developing innovative health products utilizing unique and patented technologies. They have developed a technology designed to treat and reverse the plaques that accumulate in the brain thus enhancing the quality of life, the cognitive functions of...

Read more

Abattis Announced Private Placement Agreement of Up To $5,000,000

December 8, 2016 5:12 PM

VANCOUVER, BC / ACCESSWIRE / December 8, 2016 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), is pleased to announce that the Company entered into a non-binding agreement for a draw-down equity facility of up to $5,000,000 CAD. The agreement provides for equity private placement offerings (the "Offerings"), to be conducted between Abattis and Alumina Partners (Ontario) Ltd. ("Alumina Partners"), a subsidiary...

Read more

AzurRx BioPharma to Present at the 9th Annual LD Micro Main Event

November 30, 2016 5:17 PM

LOS ANGELES, CA / ACCESSWIRE / November 30, 2016 / AzurRx BioPharma, Inc. (NASDAQ: "AZRX"), a development stage biopharmaceutical company focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome related conditions, announced today that it will be presenting at the 9th annual LD Micro Main Event on Tuesday, December 6th at 12:30PM PST / 3:30 PM EST at the Luxe Sunset Boulevard Hotel in Los...

Read more

Biomerica to Present at the 9th Annual LD Micro Main Event

November 30, 2016 9:00 AM

LOS ANGELES, CA / ACCESSWIRE / November 30, 2016 / Biomerica, Inc. (NASDAQ: BMRA) , Biomerica, Inc. (www.biomerica.com) a global provider of advanced diagnostic products announced today that it will be presenting at the 9th annual LD Micro Main Event on Wednesday, December 7 at 7:30 AM PST / 10:30 AM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Zack Irani, CEO of Biomerica, Inc. will be presenting, as well as meeting with...

Read more

MabVax Therapeutics to Present at the 9th Annual LD Micro Main Event

November 29, 2016 8:30 AM

SAN DIEGO, CA / ACCESSWIRE / November 29, 2016 / MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX), a clinical stage immuno-oncology drug development company announced today that it will be presenting at the 9th annual LD Micro Main Event on Wednesday, December 7 at 2:00 PM PST / 5:00 PM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. President and CEO J., David Hansen, of MabVax Therapeutics will be presenting, as well as meeting...

Read more

Scientific Expert, Dr. Roger Esteban-Vives, Joins RenovaCare to Advance its SkinGun Technology for Spraying Stem Cells onto Burns

November 21, 2016 9:15 AM

NEW YORK, NY / ACCESSWIRE / November 21, 2016 / RenovaCare, Inc., (OTC: RCAR), developer of the patented CellMist™ and SkinGun™ technologies* for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of Roger Esteban-Vives, Ph.D. as Director of Cell Sciences. "I'm thrilled to be joining the RenovaCare team to help bring to market the company's breakthrough...

Read more

BioSig Technologies to Present at the 9th Annual LD Micro Main Event

November 21, 2016 8:00 AM

LOS ANGELES, CA / ACCESSWIRE / November 21, 2016 / BioSig Technologies, Inc. (BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP) signal acquisition and analysis system, announced today that its President and CEO, Gregory Cash will be presenting at the 9th Annual LD Micro Main Event on Wednesday, December 7 at 11:30 AM PST / 2:30 PM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA....

Read more

Avolynt To Present at AASLD's The Liver Meeting 2016

November 9, 2016 12:40 PM

RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / November 9, 2016 / Avolynt, Inc. ("Avolynt"), a privately held biotech company focused on the development of therapeutics for metabolic diseases, announced today that it will present at The Liver Meeting® 2016 held by the American Association for the Study of Liver Diseases (AASLD), taking place November 11-15, 2016, at the John B. Haynes Veterans Memorial Convention Center in Boston. Avolynt Chief...

Read more

Vitro Biopharma Files New Patents for Stem Cell Therapy of Neurological Conditions

November 7, 2016 9:45 AM

GOLDEN, CO / ACCESSWIRE / November 7, 2016 / Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced the filing of four new patent applications at the United States Patent Office seeking protection of its proprietary stem cell products and technology related to treatment of neurological conditions. The new patents cover technology related to activation of stem cells within the brain as well as unique combinations of stem cell...

Read more

Biotech Innovator Morphogenesis, Inc. Launches Hi-Tech Digital Stock Offering to Fight Cancer

October 19, 2016 9:30 AM

TAMPA, FL / ACCESSWIRE / October 19, 2016 / Morphogenesis, Inc., a biotechnology company headquartered in Tampa, FL, announces its plans to raise up to $20 million from the sale of its common stock to accredited investors. The company is not only embracing new securities industry rules, it is launching what it hopes to be a uniquely efficient capital raising process made possible by the confluence of social and technological changes. "We...

Read more

Accurexa and StemImmune Collaborate to Develop Stem Cell-mediated Immunotherapy for Cancer

October 17, 2016 8:00 AM

WALNUT CREEK and SAN DIEGO, CA / ACCESSWIRE / October 17, 2016 / Accurexa Inc. ("Accurexa") (OTCQB: ACXA), a biotechnology company focused on the development of novel neurological therapies to be directly delivered into the brain, announced today a collaboration with StemImmune Inc. ("StemImmune") to develop its stem cell-mediated immunotherapy for the treatment of cancer, such as brain cancer. StemImmune's immunotherapy uses the stealth...

Read more

Caladrius Biosciences, Inc. to Present at The MicroCap Conference on October 24-25 in Philadelphia

October 11, 2016 11:52 AM

ARLINGTON, VA / ACCESSWIRE / October 11, 2016 / Caladrius Biosciences, Inc. (NASDAQ: CLBS) will be presenting at this year's The MicroCap Conference on October 24-25 in Philadelphia at the Hotel Monaco, along with 60 other companies in the microcap universe. The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the...

Read more

Galectin Therapeutics, Inc. to Present at The MicroCap Conference on October 24-25 in Philadelphia

October 11, 2016 11:49 AM

ARLINGTON, VA / ACCESSWIRE / October 11, 2016 / Galectin Therapeutics, Inc. (NASDAQ:GALT) will be presenting at this year's The MicroCap Conference on October 24-25 in Philadelphia at the Hotel Monaco, along with 60 other companies in the microcap universe. The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the...

Read more

ProMIS Neurosciences Inc. to Present at The MicroCap Conference on October 24-25 in Philadelphia

October 11, 2016 11:38 AM

ARLINGTON, VA / ACCESSWIRE / October 11, 2016 / ProMIS Neurosciences Inc. (OTC:ARFXF) will be presenting at this year's The MicroCap Conference on October 24-25 in Philadelphia at the Hotel Monaco, along with 60 other companies in the microcap universe. The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most...

Read more